JP2000516201A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516201A5
JP2000516201A5 JP1997542941A JP54294197A JP2000516201A5 JP 2000516201 A5 JP2000516201 A5 JP 2000516201A5 JP 1997542941 A JP1997542941 A JP 1997542941A JP 54294197 A JP54294197 A JP 54294197A JP 2000516201 A5 JP2000516201 A5 JP 2000516201A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997542941A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000516201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/009158 external-priority patent/WO1997045137A1/en
Publication of JP2000516201A publication Critical patent/JP2000516201A/ja
Publication of JP2000516201A5 publication Critical patent/JP2000516201A5/ja
Ceased legal-status Critical Current

Links

JP09542941A 1996-05-31 1997-05-30 血管形成阻害方法及び血管形成阻害に有用な組成物 Ceased JP2000516201A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1586996P 1996-05-31 1996-05-31
US1877396P 1996-05-31 1996-05-31
US60/015,869 1996-05-31
US60/018,773 1996-05-31
PCT/US1997/009158 WO1997045137A1 (en) 1996-05-31 1997-05-30 Methods and compositions useful for inhibition of angiogenesis

Publications (2)

Publication Number Publication Date
JP2000516201A JP2000516201A (ja) 2000-12-05
JP2000516201A5 true JP2000516201A5 (enExample) 2005-01-13

Family

ID=26687900

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09542941A Ceased JP2000516201A (ja) 1996-05-31 1997-05-30 血管形成阻害方法及び血管形成阻害に有用な組成物

Country Status (7)

Country Link
US (1) US6500924B1 (enExample)
JP (1) JP2000516201A (enExample)
CN (1) CN1226172A (enExample)
AU (2) AU733303C (enExample)
PT (1) PT951295E (enExample)
RU (2) RU2194528C2 (enExample)
SK (2) SK163298A3 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2227265C (en) * 1995-08-14 2012-01-03 The Scripps Research Institute Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
US7053041B1 (en) * 1996-05-31 2006-05-30 The Scripps Research Institute Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
US20040063790A1 (en) * 1996-05-31 2004-04-01 The Scripps Research Institute Methods for inhibition of angiogenesis
US20050281821A1 (en) * 1999-01-06 2005-12-22 Flavia Pernasetti Method and composition for angiogenesis inhibition
DE60045314D1 (de) * 1999-10-06 2011-01-13 Kaneka Corp Verfahren zur herstellung eines polyimidharzes
KR20030080013A (ko) * 2001-02-21 2003-10-10 에자이 가부시키가이샤 인테그린 발현 억제를 통한 혈관 신생 억제제의 효과를검정하는 방법
US7019108B2 (en) * 2001-06-01 2006-03-28 University Of Southern California Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2
AU2002319282B2 (en) * 2001-08-01 2007-06-28 Merck Patent Gmbh Integrin inhibitors for the treatment of eye diseases
US7301006B2 (en) * 2002-07-16 2007-11-27 Wisconsin Alumni Research Foundation Methods and materials for the synthesis of modified peptides
FR2856598B1 (fr) * 2003-06-25 2005-10-28 Inst Nat Sante Rech Med Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
EP2275445A3 (en) 2004-03-12 2012-02-29 Vasgene Therapeutics, Inc. Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
RU2361614C2 (ru) * 2004-03-24 2009-07-20 ПиДиЭл БАЙОФАРМА, ИНК. ПРИМЕНЕНИЕ АНТИТЕЛ ПРОТИВ α5β1 ДЛЯ ИНГИБИРОВАНИЯ ПРОЛИФЕРАЦИИ РАКОВЫХ КЛЕТОК
CN1997394B (zh) * 2004-04-14 2012-11-28 健泰科生物技术公司 含有用于调节血管发育的egfl7拮抗剂的组合物及方法
US7973134B2 (en) * 2004-07-07 2011-07-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
WO2006034455A2 (en) 2004-09-23 2006-03-30 Vasgene Therapeutics, Inc. Polipeptide compounds for inhibiting angiogenesis and tumor growth
US7935790B2 (en) * 2004-10-04 2011-05-03 Cell Singaling Technology, Inc. Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
US7807789B2 (en) * 2004-12-21 2010-10-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
WO2006072563A2 (en) * 2005-01-03 2006-07-13 F. Hoffmann-La Roche Ag Hemopexin-like structure as polypeptide-scaffold
MX2007010384A (es) * 2005-02-24 2007-10-18 Scripps Research Inst Revascularizacion de tejido retinado isquemico y metodo de seleccion para el mismo.
US20090099340A1 (en) * 2007-10-12 2009-04-16 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
US20060286148A1 (en) * 2005-05-18 2006-12-21 Ppd, Inc. Method of forming implants
AU2006283174A1 (en) * 2005-08-24 2007-03-01 Cell-Matrix, Inc. Combination therapies for inhibiting integrin-extracellular matrix interactions
WO2007027906A2 (en) * 2005-08-31 2007-03-08 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
US20100151495A9 (en) * 2005-08-31 2010-06-17 Cell Signaling Technolgy, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
JP2009513949A (ja) * 2005-09-20 2009-04-02 エンブレクス,インコーポレイテッド 鳥卵の胚盤葉の位置を迅速かつ正確に特定する方法
EP2998318A1 (en) * 2005-11-04 2016-03-23 Genentech, Inc. Use of complement pathway inhibitors to treat ocular diseases
CA2636577C (en) 2006-01-12 2015-09-15 Alexion Pharmaceuticals, Inc. Antibodies to ox-2/cd200 and uses thereof
EP1981539B1 (en) * 2006-02-09 2014-07-23 Amgen Research (Munich) GmbH Treatment of metastatic breast cancer
US20090298093A1 (en) * 2006-04-27 2009-12-03 Roberto Polakiewicz Reagents for the Detection of Protein Phosphorylation in ATM & ATR Kinase Signaling Pathways
EP1862541A1 (en) * 2006-06-01 2007-12-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Polypeptides derived from the hemopexin-like domain of metalloproteinase MMP-2
US7939636B2 (en) * 2006-08-11 2011-05-10 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in c-Src signaling pathways
US20090258442A1 (en) * 2006-08-31 2009-10-15 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
CN101835485B (zh) 2007-02-01 2016-10-26 阿塞勒隆制药公司 活化素-actriia拮抗剂及在治疗或预防乳腺癌中的用途
US20090081659A1 (en) 2007-03-07 2009-03-26 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
US20090068684A1 (en) * 2007-03-26 2009-03-12 Cell Signaling Technology, Inc. Serine and threoninephosphorylation sites
US20080238709A1 (en) * 2007-03-28 2008-10-02 Faramarz Vaziri One-way communication apparatus with dynamic key generation
EP2145902A3 (en) 2007-04-19 2010-09-29 Peter Hornbeck Tyrosine phosphorylation sites and antibodies specific for them
EP1983003A3 (en) 2007-04-19 2009-03-11 Peter Hornbeck Tyrosine phosphorylation sites and antibodies specific for them
US7977462B2 (en) 2007-04-19 2011-07-12 Cell Signaling Technology, Inc. Tyrosine phosphorylation sites
US20090053831A1 (en) 2007-05-01 2009-02-26 Cell Signaling Technology, Inc. Tyrosine phosphorylation sites
JP2010539236A (ja) 2007-09-18 2010-12-16 アクセルロン ファーマ, インコーポレイテッド アクチビン−ActRIIa拮抗薬およびFSH分泌を低減または阻害するための使用
EP2062920A3 (en) 2007-11-21 2009-06-17 Peter Hornbeck Protein phosphorylation by basophilic serine/threonine kinases in insulin signalling pathways
US20090220991A1 (en) * 2008-02-29 2009-09-03 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in leukemia signaling pathways
KR102237243B1 (ko) 2009-11-10 2021-04-07 알레그로 파마슈티칼스, 인코포레이티드. Rgd 바인딩 부위에 대한 세포 부착의 저해 또는 진단제 또는 치료제의 유도를 위한 조성물 및 방법
US11673914B2 (en) 2009-11-10 2023-06-13 Allegro Pharmaceuticals, LLC Peptide therapies for reduction of macular thickening
RU2429836C1 (ru) * 2010-04-01 2011-09-27 Максуд Мухамеджанович Расулов СРЕДСТВО, СТИМУЛИРУЮЩЕЕ ЭКСПРЕССИЮ МАТРИЧНОЙ РНК ТРИПТОФАНИЛ-тРНК-СИНТЕТАЗЫ
EP2624916B1 (en) * 2010-10-07 2018-01-17 Aerpio Therapeutics, Inc. Thiadiazole derivatives for use in the treatment of ocular edema
WO2012154894A2 (en) 2011-05-09 2012-11-15 Allegro Pharmaceuticals, Inc. Integrin receptor antagonists and their methods of use
HK1206610A1 (en) 2012-03-30 2016-01-15 Sorrento Therapeutics, Inc. Fully human antibodies that bind to vegfr2
CN110191721A (zh) 2016-09-26 2019-08-30 集合集团控股公司 有淋巴系统失调的受试者中癌症的评估与治疗方法
WO2018183894A1 (en) * 2017-03-31 2018-10-04 The Regents Of The University Of California Compositions and methods for targeting and killing alpha-v beta-3-positive cancer stem cells (cscs) and treating drug resistant cancers
CN113663929A (zh) * 2021-09-24 2021-11-19 深圳市广利达精密机械有限公司 一种自动化机械加工零件自动加工分拣设备及其方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5092885A (en) 1987-02-12 1992-03-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Peptides with laminin activity
AU2807189A (en) 1987-11-19 1989-07-05 Scripps Clinic And Research Foundation Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells
JPH01169343A (ja) 1987-12-25 1989-07-04 Nippon Sheet Glass Co Ltd ガラス板の切口欠点検出装置
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
IE64346B1 (en) 1988-01-19 1995-07-26 Moses Judah Folkman Growth inhibiting agent and the use thereof
US5575815A (en) 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5843897A (en) 1989-06-16 1998-12-01 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5112946A (en) 1989-07-06 1992-05-12 Repligen Corporation Modified pf4 compositions and methods of use
US5192744A (en) 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
ATE130517T1 (de) 1990-08-08 1995-12-15 Takeda Chemical Industries Ltd Intravaskulär embolisierendes mittel mit gehalt an einem die angiogenesis hemmenden stoff.
JP3353209B2 (ja) 1992-04-03 2002-12-03 ジェネンテク,インコーポレイテッド αvβ3インテグリンに対する抗体
SK57693A3 (en) 1992-06-18 1994-07-06 Merck Patent Gmbh Linear peptides and pharmaceutical agents on their base
UA43823C2 (uk) 1992-07-06 2002-01-15 Мерк Патент Геселлшафт Міт Бесшренктер Хафтунг ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ІНТЕГРИН <font face="Symbol">a</font><sub>V</sub><font face="Symbol">b</font><sub>3</sub>-ОПОСЕРЕДКОВАНОЇ КЛІТИННОЇ АДГЕЗІЇ КЛІТИН ССАВЦІВ, СПОСІБ ЛІКУВАННЯ ТА ПРОФІЛАКТИКИ ЗАХВОРЮВАННЯ, АСОЦІЙОВАНОГО З ПОРУШЕННЯМ АДГЕЗІЇ КЛІТИН, СПОСІБ БЛОКУВАННЯ ЗВ'ЯЗУВАННЯ ФІБРИНОГЕНОМ ІНТЕГРИНУ, КОМПОЗИЦІЯ ДЛЯ ЗАГОЄННЯ РАН
DE4310643A1 (de) 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5981478A (en) 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
US5770565A (en) 1994-04-13 1998-06-23 La Jolla Cancer Research Center Peptides for reducing or inhibiting bone resorption
DE19534177A1 (de) 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
DE19538741A1 (de) 1995-10-18 1997-04-24 Merck Patent Gmbh Cyclopeptidderivate

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2002512727A5 (enExample)
JP2001510326A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000501324A5 (enExample)
JP2001503087A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000516201A5 (enExample)
JP2001507029A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000504115A5 (enExample)
JP2001501336A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)